Literature DB >> 10851088

Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.

J Bies1, S Feiková, D P Bottaro, L Wolff.   

Abstract

The c-myb proto-oncogene encodes a nuclear phosphoprotein that plays a crucial role in normal hematopoiesis. It is a short-lived transcription factor rapidly degraded by the 26S proteasome. Although it has been shown that instability determinants reside in its carboxyl terminus, the molecular mechanism of c-Myb degradation is unknown. Here, we report the first evidence that phosphorylation plays a role in targeting the protein to the proteasome. Inhibition of cellular serine/threonine protein phosphatase activity by okadaic acid resulted in hyperphosphorylation of c-Myb and extremely rapid turnover. The hyperphosphorylation resulted in a protein with altered properties that was indicative of conformational changes. Its mobility on gel electrophoresis was altered as well as its recognition by specific monoclonal antibody. The altered hyperphosphorylated protein still bound to DNA with an affinity similar to that of the hypophosphorylated form. Phosphorylation of three previously identified sites, serines 11, 12, and 528, does not appear to be involved in the proposed changes in conformation or stability. However, phosphoamino acid analyses of the hyperphosphorylated form of c-Myb revealed increased c-Myb phosphorylation mainly on threonine residues that correlated with other okadaic acid-induced alterations of c-Myb. These findings indicate that Ser/Thr phosphatases prevent conformational changes that may play an important role in controlled degradation of c-Myb. Oncogene (2000) 19, 2846 - 2854

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10851088     DOI: 10.1038/sj.onc.1203613

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

Authors:  G Li; J A Harton; X Zhu; J P Ting
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  ALY is a common coactivator of RUNX1 and c-Myb on the type B leukemogenic virus enhancer.

Authors:  Jennifer A Mertz; Ryuji Kobayashi; Jaquelin P Dudley
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Stress-induced phosphorylation of Thr486 in c-Myb by p38 mitogen-activated protein kinases attenuates conjugation of SUMO-2/3.

Authors:  Juraj Bies; Marek Sramko; Linda Wolff
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

4.  Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cdelta.

Authors:  Jyoti Srivastava; Katarzyna J Procyk; Xavier Iturrioz; Peter J Parker
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 5.  Myb proteins: angels and demons in normal and transformed cells.

Authors:  Ye Zhou; Scott A Ness
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

6.  Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Authors:  Jacqueline Corrigan-Curay; Odile Cohen-Haguenauer; Marina O'Reilly; Susan R Ross; Hung Fan; Naomi Rosenberg; Nikunj Somia; Nancy King; Theodore Friedmann; Cynthia Dunbar; Alessandro Aiuti; Luigi Naldini; Christopher Baum; Christof von Kalle; Hans-Peter Kiem; Eugenio Montini; Frederic Bushman; Brian P Sorrentino; Manuel Carrondo; Harry Malech; Gösta Gahrton; Robyn Shapiro; Linda Wolff; Eugene Rosenthal; Robert Jambou; John Zaia; Donald B Kohn
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

7.  Dramatic repositioning of c-Myb to different promoters during the cell cycle observed by combining cell sorting with chromatin immunoprecipitation.

Authors:  Anita M Quintana; Ye E Zhou; Janeth J Pena; John P O'Rourke; Scott A Ness
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

8.  Identification and regulation of c-Myb target genes in MCF-7 cells.

Authors:  Anita M Quintana; Fan Liu; John P O'Rourke; Scott A Ness
Journal:  BMC Cancer       Date:  2011-01-25       Impact factor: 4.430

9.  GSK3 regulates the expressions of human and mouse c-Myb via different mechanisms.

Authors:  Kyoko Kitagawa; Yojiro Kotake; Yoshihiro Hiramatsu; Ning Liu; Sayuri Suzuki; Satoki Nakamura; Akira Kikuchi; Masatoshi Kitagawa
Journal:  Cell Div       Date:  2010-11-21       Impact factor: 5.130

10.  DDR2 controls the epithelial-mesenchymal-transition-related gene expression via c-Myb acetylation upon matrix stiffening.

Authors:  Daehwan Kim; Eunae You; Jangho Jeong; Panseon Ko; Jung-Woong Kim; Sangmyung Rhee
Journal:  Sci Rep       Date:  2017-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.